|

Digital Long-term Follow-up of Patients With Coronary Artery Disease

RECRUITINGN/ASponsored by Oslo University Hospital
Actively Recruiting
PhaseN/A
SponsorOslo University Hospital
Started2026-04-01
Est. completion2028-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The need for better follow-up of AMI patients combined with recent developments in the digital area prompted the Department of Cardiology (HJE) at Oslo University Hospital (OUS) Ullevål, in collaboration with the Department of Digital Health Research (DIG) at OUS to develop a digital solution for long-term follow-up after AMI. The overall goal of the digital solution is to increase knowledge and awareness about important lifestyle measures and CV risk factors in patients who have survived an AMI, and to make it easy for the patients to monitor their own risk factors and attainment of treatment goals during long-term follow-up. Further, the HeartCheck seeks to provide guidance to ensure medication adherence. In this project, we study whether this newly developed app (HeartCheck), through education, regular reminders and easily understandable goals for secondary prevention, can improve risk factor control and drug adherence during long-term follow-up after AMI. A randomized controlled trial (RCT) is the chosen study design, being the gold standard for testing effectiveness of interventions.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* \>18 years of age
* survived a recent (\<30 days) AMI and/or PCI
* access to a smartphone or tablet
* signed written informed consent

Exclusion Criteria:

* patient does not understand Norwegian
* patient is unable to comply with the study procedures due to severe comorbidities or high age

Conditions2

Coronary Artery DiseaseHeart Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.